US clears Pfizer’s biosimilar or Epogen, Procrit

16th May 2018 Uncategorised 0

The US Food and Drug Administration has approved Pfizer’s Retacrit, a biosimilar of Amgen’s Epogen and Johnson & Johnson’s Procrit.

More: US clears Pfizer’s biosimilar or Epogen, Procrit
Source: News